Abstract
One of the great discoveries in cardiac electrophysiology was the recognition of the crucial role of pulmonary vein (PV) myocardial sleeves for the initiation of atrial fibrillation (AF). Based on this concept, catheter ablation aiming at electrical isolation of all pulmonary veins has become the routine approach for of paroxysmal AF. Another concept implies selective isolation only of arrhythmogenic PVs. Based on the most important studies dealing with both approaches, we describe pros and cons of selective compared to complete pulmonary vein isolation (PVI) and illustrate why selective PVI has not found widespread acceptance in the electrophysiologic community.
Introduction
The recognition of the crucial role of pulmonary vein (PV) myocardial sleeves for the initiation of atrial fibrillation (AF) initiation is regarded as one of the greatest discoveries of the last decades in cardiac electrophysiology.[1,2,3] Many ablation strategies are based on this concept and the initial punctual approach progressed to more extensive ablation.[4-8] Overall, pulmonary vein isolation (PVI) has become a cornerstone of AF ablation.
Experimental studies had demonstrated the electrophysiological properties of PVs.[9] PVs possess a substrate for microreentry, which was shown by extrastimulus testing. The proximal PV has a significantly slower conduction compared to the rest of the left atrium (LA) with decremental conduction and variable entrance block observed at faster atrial pacing rates. Focal discharge in proximity to the area of slow conduction is also present with isoproterenol. Clinical studies demonstrated the distinctive properties of arrhythmogenic PVs.[10] Selective identification and isolation of the arrhythmogenic PVs might therefore be preferable to a systematic complete PVI. However, due to several factors which we will discuss below, selective PVI has not become the routine approach for AF ablation.
Does Selective PVI Achieve A Similar Outcome Compared To Complete PVI?
Table 1 shows the results of the 3 randomized trials comparing isolation of arrhythmogenic vs. all PVs.[11-13] Arrhythmia freedom at 12 months without antiarrhythmic drugs (AAD) after a single procedure was achieved in 53-62% by selective isolation of the arrhythmogenic vein(s) and in 59-74% by PVI of all veins. The slightly different results might be explained by different ablation approaches (segmental vs. circumferential PVI, irrigated vs. non irrigated tip catheter). The tendency towards higher success rates with complete PVI did not reach statistical significance in any of the 3 studies, perhaps due to small patient number or short follow-up.
Table 1. Results of the 3 randomized trials comparing isolation of arrhythmogenic vs. all PVs.
RF: radiofrequency, AAD: antiarrhythmic drugs, PV: pulmonary vein, AF: atrial fibrillation, LA: left atrium, RA: right atrium, APC: atrial premature beat, min.: minutes
| Study | Patients (n) | Provocative manoeuver | Definition of arrhythmogenic vein(Possible selection, %) | Number of arrhythmo-genic veins | Procedure time(min.) | Fluoroscopy time (min.) | RF applications/ RF time | Freedom from arrhythmia recurrence after a single ablation off AAD (%) |
|---|---|---|---|---|---|---|---|---|
| Fichtner et al. 2012[11] | 207 | Programmed stimulation with a single extrastimulus (± orciprenaline) from inside each PV | - Spontaneous or pacing-induced AF or atrial runs from distally inside the PV.- PV with the most pronounced decremental conduction properties at the PV-LA junction. (97%) | 2.1±1.0 | 152.3±57.1 vs. 162±68.9 (p= n.s) | 27.7±14.2 vs. 33.5±19.5 (p =0.016) | 33.9±22.9 vs. 47.6±21.1 (p =0.001) | 53% vs. 59%(p =0.51). |
| Pak et al. 2008[12] | 77 | - SustainedAF induced by high-rate right atrial burst stimulation, if necessary with isoproterenol administration. - After internalcardioversion mapping of the reinitiating APC | Reinitiation of AF from the same PV at least three times (33%) | 1.5±0.6 | 186.7±78.7 vs. 325.8±107.6 (p<0.01) | 54.0±17.6 vs. 97.5±31.1 (p<0.01) | 51.0 ± 16.4 min. vs. 127.2 ± 60.3 (p<0.01) | 62% vs. 74% (p=n.s) |
| Dixit et al. 2007[13] | 105 | Isoproterenol infusion and AF induction by LA or RA burst pacing | - PV documented to initiate AF and/oratrial premature complexes based on direct intracardiac recordings and/or activation sequences of multipolar catheters located in the posterior RA and coronary sinus mimicking PV pace maps (98%) | 2.9 ± 0.9 | 317±88 vs. 327±93 (p=n.s) | 85±33 vs. 97±36 (p= ns.) | 20±10 vs. 17±9 | 61% vs. 59% (p=n.s) |
What Are The Benefits Of Selective PVI?
Selective PVI potentially saves procedure duration, fluoroscopy duration, radiofrequency (RF) energy and thereby diminishes complications. However, a lower procedural duration was demonstrated in only one of the 3 randomized trials;[12] procedure duration in this study appears to be long in both groups (186.7 ± 78.7 min. vs. 325.8 ± 107.6 min., p<0.01). A significant reduction in fluoroscopy and RF time was achieved in 2 studies[11,12] (table 1), which is relevant for both patient and operator. None of the studies was powered enough to show a difference in complication rate.
What Are The Flaws Of Selective PVI?
Different And Laborious Protocols To Define The Arrhythmogenic PV
Most of the studies use laborious protocols to identify arrhythmogenic veins. Mapping of spontaneous atrial premature contraction (APC) can be accurate if these are repetitive and monomorphic. However, as in the study of Haisaguerre et al.,[14] spontaneous ectopy is often absent and AF duration variable. Thus, in the majority of cases provocative maneuvers including atrial bursts, isoproterenol infusion, adenosine triphosphate disodium injection, carotid sinus massage, Valsalva maneuver or even administration of effervescent agents or smoking were necessary to induce AF.[8] Cardioversion of pacing-induced AF followed by observation of spontaneous arrhythmias was also used.[15] In the study of Pak et al.,[12] a PV was defined as arrhythmogenic if AF reinitiation after cardioversion occurred from the same PV at least 3 times. With this protocol, arrhythmogenic veins were defined in only 33% of the population. Dixit et al.[13] found arrhythmogenic PVs in 98% of patients based on direct intracardiac recordings and/or activation sequences of multipolar catheters located in the posterior right atrium and coronary sinus. This difference shows that catheter placement for PV mapping and definition of arrhythmogenitiy vary widely among operators. Jais et al.[4] demonstrated that PVs in AF patients have distinctive electrophysiological properties consisting of short effective refractory periods (ERP) with decremental and slow conduction. In this study, AF was preferentially induced after a single extrastimulus from the vein suggesting that inducibility depends on proximity to critical areas (with short ERP and long conduction time) such as PVs. Based on these findings, Fichtner et al.[11] developed a simple and reproducible protocol for selection of arrhythmogenic PVs. Programmed stimulation with a single extrastimulus (if necessary with orciprenaline) was performed from inside each vein and showed a high rate of AF induction (78%) or PV triggers (7%). If AF was not induced, the PV with the most pronounced decremental conduction properties at the PV-LA junction was considered arrhythmogenic (15%). Following this protocol, arrhythmogenic veins were identified in 97% of patients.
Development Of “New” Arrhythmogenic PVs During Follow-Up
The main concern regarding ablation of arrhythmogenic PVs is the status of the autonomic nervous system which might differ between the electrophysiological study and “real life”. PVs demonstrated to be non- arrhythmogenic might become arrhythmogenic and vice versa. This is supported by the findings of the study of Pak et al.[12] In this study, very late recurrence occurred more often in the selective PVI group (19% vs. 5.7%). During the reablation procedure, only 53.8% of the arrhythmogenic foci were at previously ablated PVs, suggesting that “new” veins were now arrhythmogenic. In the study of Dixit et al.,[13] triggers identified from reconnected PVs during redo procedures were demonstrated in 74% of patients.
Which Patients Might Benefit From Selective PVI ?
Haisaguerre et al.[14] demonstrated that the prevalence of multiple arrhythmogenic PVs was high (69%) and associated with older age, longer AF duration, and larger atrial dimensions. In the retrospective study of Gerstenfeld et al,[15] patients with ≤2 arrhythmogenic PVs had similar results than patients with ≥3 arrhythmogenic PVs (58% vs. 65%, p= n.s). However, patients younger than 50 years undergoing isolation of ≤2 PVs had the best outcome (73%). In the study of Fichtner et al.,[11] a tendency toward a better outcome was shown in patients with only one arrhythmogenic PV (63% vs. 59%, p= 0.12). Young patients with clearly only one firing PV (even spontaneous or after provocation) appear to be the best target group for selective PVI. However, knowing the high rate of electrical connections between contiguous PVs, ipsilateral PVI might be required.[16] One non randomized study showed similar results between ipsilateral and bilateral PVI of focal PV triggered paroxysmal AF.[17] In the subgroup of patients aged ≥50 years with an LA diameter ≥40 mm, ipsilateral PVI appeared to be insufficient with AF freedom achieved in only 17% vs. 65% after bilateral PVI.
Conclusion
Selective isolation of arrhythmogenic PVs has not been established as a routine approach for paroxysmal AF ablation. This is mainly due to methodological problems to identify the arrhythmogenic vein and evidence that PV arrhythmogeneity is not a static feature but might vary under the influence of the autonomic nervous system. As complete PVI has become a routine procedure with low complication rates, a systematical isolation of all PVs is usually warranted. However, in selected young patients with a single triggering PV focus, selective PVI represents an elegant and effective approach.
Disclosures
None.
References
- 1.Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation. 1966 Sep;34 (3):412–22. doi: 10.1161/01.cir.34.3.412. [DOI] [PubMed] [Google Scholar]
- 2.Ho S Y, Cabrera J A, Tran V H, Farré J, Anderson R H, Sánchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart. 2001 Sep;86 (3):265–70. doi: 10.1136/heart.86.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Haïssaguerre M, Jaïs P, Shah D C, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998 Sep 3;339 (10):659–66. doi: 10.1056/NEJM199809033391003. [DOI] [PubMed] [Google Scholar]
- 4.Jaïs P, Haïssaguerre M, Shah D C, Chouairi S, Gencel L, Hocini M, Clémenty J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997 Feb 4;95 (3):572–6. doi: 10.1161/01.cir.95.3.572. [DOI] [PubMed] [Google Scholar]
- 5.Haïssaguerre M, Shah D C, Jaïs P, Hocini M, Yamane T, Deisenhofer I, Chauvin M, Garrigue S, Clémenty J. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation. 2000 Nov 14;102 (20):2463–5. doi: 10.1161/01.cir.102.20.2463. [DOI] [PubMed] [Google Scholar]
- 6.Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation. 2000 Nov 21;102 (21):2619–28. doi: 10.1161/01.cir.102.21.2619. [DOI] [PubMed] [Google Scholar]
- 7.Karch Martin R, Zrenner Bernhard, Deisenhofer Isabel, Schreieck Jürgen, Ndrepepa Gjin, Dong Jun, Lamprecht Katrin, Barthel Petra, Luciani Etienne, Schömig Albert, Schmitt Claus. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005 Jun 7;111 (22):2875–80. doi: 10.1161/CIRCULATIONAHA.104.491530. [DOI] [PubMed] [Google Scholar]
- 8.Takahashi Atsushi, Iesaka Yoshito, Takahashi Yoshihide, Takahashi Ryoko, Kobayashi Kenzaburo, Takagi Katsumasa, Kuboyama Osamu, Nishimori Takeo, Takei Hidenobu, Amemiya Hiroshi, Fujiwara Hideomi, Hiraoka Masayasu. Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation. Circulation. 2002 Jun 25;105 (25):2998–3003. doi: 10.1161/01.cir.0000019585.91146.ab. [DOI] [PubMed] [Google Scholar]
- 9.Arora Rishi, Verheule Sander, Scott Luis, Navarrete Antonio, Katari Vikram, Wilson Emily, Vaz Dev, Olgin Jeffrey E. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation. 2003 Apr 8;107 (13):1816–21. doi: 10.1161/01.CIR.0000058461.86339.7E. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jaïs Pierre, Hocini Mélèze, Macle Laurent, Choi Kee-Joon, Deisenhofer Isabel, Weerasooriya Rukshen, Shah Dipen C, Garrigue Stéphane, Raybaud Florence, Scavee Christophe, Le Metayer Philippe, Clémenty Jacques, Haïssaguerre Michel. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation. 2002 Nov 5;106 (19):2479–85. doi: 10.1161/01.cir.0000036744.39782.9f. [DOI] [PubMed] [Google Scholar]
- 11.Fichtner Stephanie, Hessling Gabriele, Ammar Sonia, Reents Tilko, Estner Heidi L, Jilek Clemens, Kathan Susanne, Büchner Michael, Dillier Roger, Deisenhofer Isabel. A prospective randomized study comparing isolation of the arrhythmogenic vein versus all veins in paroxysmal atrial fibrillation. Clin Cardiol. 2013 Jul;36 (7):422–6. doi: 10.1002/clc.22132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pak Hui-Nam, Kim Jin Seok, Shin Seung Yong, Lee Hyun Soo, Choi Jong Il, Lim Hong Euy, Hwang Chun, Kim Young-Hoon. Is empirical four pulmonary vein isolation necessary for focally triggered paroxysmal atrial fibrillation? Comparison of selective pulmonary vein isolation versus empirical four pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 2008 May;19 (5):473–9. doi: 10.1111/j.1540-8167.2007.01074.x. [DOI] [PubMed] [Google Scholar]
- 13.Dixit Sanjay, Gerstenfeld Edward P, Ratcliffe Sarah J, Cooper Joshua M, Russo Andrea M, Kimmel Stephen E, Callans David J, Lin David, Verdino Ralph J, Patel Vickas V, Zado Erica, Marchlinski Francis E. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study. Heart Rhythm. 2008 Feb;5 (2):174–81. doi: 10.1016/j.hrthm.2007.09.024. [DOI] [PubMed] [Google Scholar]
- 14.Haïssaguerre M, Jaïs P, Shah D C, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng J T, Roudaut R, Clémenty J. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation. 2000 Mar 28;101 (12):1409–17. doi: 10.1161/01.cir.101.12.1409. [DOI] [PubMed] [Google Scholar]
- 15.Gerstenfeld Edward P, Sauer William, Callans David J, Dixit Sanjay, Lin David, Russo Andrea M, Beldner Stuart, McKernan Melissa, Marchlinski Francis E. Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation. Heart Rhythm. 2006 Feb;3 (2):165–70. doi: 10.1016/j.hrthm.2005.10.016. [DOI] [PubMed] [Google Scholar]
- 16.Matsuo Seiichiro, Jaïs Pierre, Wright Matthew, Lim Kang-Teng, Knecht Sébastien, Haïssaguerre Michel. Maintenance of atrial fibrillation by pulmonary vein tachycardia with ostial conduction block: evidence of an interpulmonary vein electrical connection. J. Cardiovasc. Electrophysiol. 2008 Oct;19 (10):1101–4. doi: 10.1111/j.1540-8167.2008.01141.x. [DOI] [PubMed] [Google Scholar]
- 17.Hu Ji-Qiang, Ma Jian, Ouyang Feifan, Yang Qian, Liao Zi-Li, Hou Yu, Zhang Shu. Is selective ipsilateral PV isolation sufficient for focally triggered paroxysmal atrial fibrillation? Comparison of selective ipsilateral pulmonary vein isolation versus bilateral pulmonary vein isolation. J. Cardiovasc. Electrophysiol. 2012 Feb;23 (2):130–6. doi: 10.1111/j.1540-8167.2011.02166.x. [DOI] [PubMed] [Google Scholar]
